Anti-smoking vaccines set to help millions kick the habit & ignite underdeveloped prescription market
Sending...
25 January 2008 | Published by Datamonitor
London – January is a time when many smokers strengthen their resolve to kick their habit, with 1.2 million estimated to have embarked on this journey this New Year’s Day in the UK alone(1). However, as smokers who have attempted and failed to quit will agree, will power by itself is often not sufficient and smoking cessation aids are often needed. Estimated to be worth just $213 million 2006**, according to a new report* from independent market analyst Datamonitor, the prescription nicotine dependence market is set to grow strongly at a compound annual growth rate (CAGR) of 16% to reach $4.6 billion by 2016**, driven by the launch of two promising pipeline nicotine vaccines and the continued uptake of Pfizer’s popular nicotine receptor agonist Chantix (varenicline).
Notes to editors
Notes & References
* Pipeline Insight: Substance Dependence – Part I: Nicotine
** Seven major markets: UK, US, France, Germany, Italy, Japan and Spain, MIDAS Sales Data, IMS Health, July 2007.
1. Office for National Statistics.
2. NICE Guidelines 2002, http://guidance.nice.org.uk.
Related Research
Datamonitor’s report Pipeline Insight: Substance Dependence – Part I: Nicotine provides analysis of drugs in late-stage clinical development for use in treating nicotine dependence, including important clinical trial results, patient potential, and drug revenue forecasts to 2016; supported by key opinion leader comments.
Further Information
Ms. Charlotte Mackey, Datamonitor central nervous system (CNS) analyst and report author is available for comment.
More information is available from the Datamonitor Group Media Team. Please contact Matthew Dick on +44 20 7675 7824 or mdick@datamonitor.com.
For US, please contact Alan Sott on +1 570 687 9315.
For Asia-Pacific, please contact Denis Mason on +61 2 8705 6903.
About Datamonitor
Datamonitor is a leading provider of online database and analysis services for key industry sectors. We help our clients, 5000 of the world's leading companies, to address complex strategic issues. Through our proprietary databases and wealth of expertise, we provide clients with unbiased expert analysis and in-depth forecasts for seven industry sectors: Automotive, Consumer Markets, Energy, Financial Services, Pharmaceuticals and Healthcare, Technology, Transport and Logistics.
